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ABSTRACT
Malaria is responsible for more than 1.5 million deaths each year, especially among children (Snow 
et al. 2005). Despite of the severity of malaria situation and great effort to the development of new drug 
targets (Yuan et al. 2011) there is still a relative low investment toward antimalarial drugs. Briefly there 
are targets classes of antimalarial drugs currently being tested including: kinases, proteases, ion channel 
of GPCR, nuclear receptor, among others (Gamo et al. 2010). Here we review malaria signal transduction 
pathways in Red Blood Cells (RBC) as well as infected RBCs and endothelial cells interactions, namely 
cytoadherence. The last process is thought to play an important role in the pathogenesis of severe malaria. 
The molecules displayed on the surface of both infected erythrocytes (IE) and vascular endothelial cells 
(EC) exert themselves as important mediators in cytoadherence, in that they not only induce structural 
and metabolic changes on both sides, but also trigger multiple signal transduction processes, leading to 
alteration of gene expression, with the balance between positive and negative regulation determining 
endothelial pathology during a malaria infection.
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INTRODUCTION
Plasmodium parasites are able to sense host signals 
to modulate their function through a complex cellular 
machinery and membrane receptors (Hotta et al. 2000, 
Garcia et al. 2008, Koyama et al. 2009). Moreover 
Ca2+ signalling pathways in Plasmodium are crucial 
for parasite development thus molecules involved in 
these pathways can be promising antimalarial targets 
(McCallum-Deighton and Holder 1992, Hotta et al. 
2000, Gazarini and Garcia 2004).
Interestingly, cytoadherence of infected 
erythrocyte is also regulated by host signalling 
responses and Plasmodium falciparum proteins 
such as PfEMP1 binding to CD36 or ICAM-1 
host receptors can modulate dendridic cells, 
monoycytes, endothelium and T cells (Urban et 
al. 1999, Ndungu et al. 2006, Chakravorty et al. 
2008, Langhorne et al. 2008) in addition to soluble 
mediators. Inhibitors of TNF (tumor necrosis factor) 
also reduced infected erythrocyte cytoadherence 
(Wassmer et al. 2006b, Chakravorty et al. 2008) 
and comparison of murine malaria strains indicates 
that host immunological responses such as TNF 
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secretion, T cell activation and pro-inflammatory 
cytokine activation lead to differences in parasite 
growth or death (Wykes and Good 2008). Based 
on this we have reviewed the importance of Ca2+ 
modulated targets as antimalarial drugs.
HOST SIGNALS AND MODULATION OF PLASMODIUM CELL CYCLE
Signal transduction regulation inside Plasmodium 
has been shown as a major mechanism controlling 
parasite development. Plasmodium is able to 
sense host signals to modulate its function through 
a complex cellular machinery and membrane 
receptors  (Garcia et al. 2008, Koyama et al. 2009). 
Moreover Ca2+ signalling pathways in Plasmodium 
are crucial for parasite development. The ion 
can be released from internal stores or from the 
extracellular medium (Gazarini and Garcia 2004, 
Hotta et al. 2000, Mccallum-Deighton and Holder 
1992). During the intraerytrocytic development 
the ion is involved in P. falciparum and P. 
chabaudi synchronization through the hormone 
melatonin and its precursors N-acetylserotonin, 
tryptamine, serotonin and N(1)-acetyl-N(2)-
formyl-5-methoxykynuramine (AFMK) (Beraldo 
et al. 2005, 2007, Budu et al. 2007, Hotta et al. 
2000). Interestingly, the presence of the hormone 
melatonin induces release of intracellular Ca2+ 
which can be blocked by PLC inhibitor or 
melatonin antagonist. Recently, it has been shown 
by caged-IP3 and confocal analysis that melatonin 
elicited intracellular Ca2+ increase though IP3-
PLC pathway in P. falciparum trophozoite (Alves 
et al. 2010). Measurements of intracellular cAMP 
and protein kinase A (PKA) activity also showed 
that melatonin triggers cAMP production and PKA 
activation (Gazarini et al. 2011).
Differences among developmental stages within 
Plasmodium falciparum signalling was reported 
and melatonin modulation was not observed in ring 
or schizont stages (Alves et al. 2010). Furthermore 
melatonin did not elicit calcium rise in the rodent 
parasites P. berghei and P. yoelii (Bagnaresi et al. 
2009) once those are asynchronous parasites with 
a distinct profile of proteolysis modulation (Cruz et 
al. 2011, Farias et al. 2005).
Another important extracellular signal that 
modulates Plasmodium-RBC interaction is ATP 
which has been described to induce increase of 
intracellular Ca2+ in P. falciparum, P. berghei and 
P. yoelii thus suggesting the presence of a putative 
purinoreceptor in the parasite (Levano-Garcia et al. 
2011, Cruz et al. in press). Erythrocytes infected 
by Plasmodium, as damaged cells, can increase 
ATP level of the medium (Akkaya et al. 2009) and 
P. falciparum was unable to infect erythrocytes 
after ATP depletion (Rangachari et al. 1986). 
Moreover, the ATP receptor blocker suramin 
binds to merozoite surface proteins-1 (MSP1) 
inhibiting its cleavage and erythrocyte invasion by 
Plasmodium falciparum merozoites (Fleck et al. 
2003). ATP is also thought to be involved in host 
induced inflammation which is followed by malaria 
infection (Clark et al. 2006).
Among the host signalling molecules 
Xanthurenic acid (XA), produced by the mosquito, 
triggers differentiation of male/female gametes, 
although it is not yet identified the parasite 
receptor for XA (Muhia et al. 2001, Ward et al. 
2004). Recently gametocyte exflagellation, DNA 
synthesis and Ca2+ mobilization was shown to be 
inhibited by U73122 indicating the importance of 
phosphoinositide-specific phospolipase C  pathway 
during gametocyte activation (Raabe et al. 2011).
Cyclic GMP-dependent protein kinase (PKG) 
might be involved in gametogenesis by cyclic 
GMP once exflagellation and rounding up of 
microgametocytes are induced in the presence of 
zaprinast (a specific inhibitor of cGMP-PDE). The 
presence of an upstream Ca2+ pathway activated 
by cyclic GMP-dependent protein kinase (PKG) 
to initiate gametogenesis (Mcrobert et al. 2008) 
is suggested. Regarding asexual stages, PKG 
is involved in the progression of P. falciparum 
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schizogony as in the presence of a PfPKG 
inhibitor formation of rings is reduced and electron 
micrographs showed alteration in schizonts 
morphology (Taylor et al. 2010).
During the Plasmodium cell cycle, Ca2+ is also 
involved in invasion of hepatocyte by triggering 
microneme secretion (Ono et al. 2008, Vaid et 
al. 2008), phosphorylation of merozoyte motility 
components via PfPKB induced by calmodulin 
(Vaid et al. 2008), translocation of microneme 
proteins (e.g. EBA175), apical membrane 
antigen-1 (AMA1) to merozoite surface (Singh 
et al. 2010) and to induce secretion of rhoptry 
protein to the merozoite surface.
Following merozoite attachment at the 
erythrocyte membrane there is a decrease in 
cytosolic Ca2+ level, similarly described in T. 
gondii tachyzoites (Singh et al. 2010, Lovett and 
Sibley 2003). This signalling mechanism might be 
a feedback to reduce further microneme protein 
secretion to merozoite surface (Singh et al. 2010).
Ca2+ MODULATED ANTIMALARIAL TARGETS
The calcium-dependent protein kinases (CDPKs) 
are only found in plants and protists (Harper and 
Harmon 2005) and interestingly the Plasmodium 
has at least 5 CDPKs  and gene knock out studies 
pointed out the importance of these kinases 
(Doerig et al. 2010, Hall et al. 2005, Ward et al. 
2004). Disruption strategies of P. falciparum 
PfCDPK1 were not successful whereas PfCDPK1 
inhibitory assays blocked the cell cycle at shizont 
stage (Kato et al. 2008). Reverse genetics studies 
carried out in Plasmodium berghei CDPK reported 
that PbCDPK3 is involved in ookinete motility in 
the mosquito midgut which requires intracellular 
Ca2+ mobilization (Ishino et al. 2006). PbCDPK4 
is calcium dependent and is involved in male 
gametocyte exflagellation induced by XA in the 
mosquito gut (Billker et al. 2004, Ward et al. 2004). 
Mutant PbCDPK6 sporozoites showed a reduced 
invasion phenotype probably due to contact with 
the host heparin sulfate proteoglycans (HSPGs) 
and cAMP-dependent protein kinase (PKA) 
activation (Coppi et al. 2007).
P. falciparum cAMP-dependent protein kinase 
(PfPKA) activity is expressed at the sexual and 
asexual stages of the parasite (Wurtz et al. 2011). 
PfPKA is involved in Ca2+ signalling pathways 
(Beraldo et al. 2005, Wurtz et al. 2009), motility 
of sporozoites, apical exocytosis, cell invasion 
(Kebaier and Vanderberg 2010, Ono et al. 2008) 
and regulation of mitochondrial protein traffic 
(Wurtz et al. 2009, De Rasmo et al. 2008).
The protein kinase B-like enzyme (PKB) in 
mammalian cells, has been shown to be involved 
in regulation of transcription factors, apoptosis 
and glycogen pathways (Alessi et al. 1996, 
Andjelkovic et al. 1997, Vanhaesebroeck and 
Alessi 2000). Interestingly in P. falciparum the 
protein kinase B-like (PfPKB) does not contain 
the PH (phosphoinositide interaction) homology 
domain and its activity is regulated by Ca2+/
CaM autophosphorylation and N-terminal region 
modulation (Vaid and Sharma 2006, Ward et 
al. 2004). PfPKB is present at the cytoplasm of 
schizonts/trophozoites and at the apical end of 
merozoites (Kumar et al. 2004). Blocking the function 
of the upstream activators of this pathway resulted 
in impaired invasion. PfPKB inhibitors dramatically 
reduced the ability of the parasite to invade 
erythrocytes and the work of PfPKB was associated 
with actin-myosin motor and phosphorylates 
PfGAP45 (glideosome-associated protein 45) (Vaid 
et al. 2008). PfPI3K, a Phosphatidyl-inositol-3-
kinase in P. falciparum was reported as a second 
messenger involved in endocytosis and trafficking 
of haemoglobin. Inhibition of PfPI3K resulted in 
attenuated hemoglobin digestion and the inhibition 
of parasite growth (Vaid et al. 2010).
It is noteworthy that protein kinase C (PKC) 
activity is not present in the P. falciparum genome 
database (Carlton et al. 2008) although it has been 
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suggested that in plants CDPK may function as 
PKC (Satterlee and Sussman 1998). Interestingly, 
the receptor for activated C kinase 1 (RACK1) is 
a protein involved in Ca2+ signalling by recruiting 
protein kinase C (PKC) isoforms, InsP3 receptors, 
proteins G and others to its substrates (Schechtman 
and Mochly-Rosen 2001, Chen et al. 2004, 
Patterson et al. 2004). In mammalian cells, RACK1 
has been shown to be involved in the circadian 
clock through interaction with PKC alpha and 
inhibition of CLOCK-BMAL1 activity (Robles 
et al. 2010). Plasmodium falciparum expresses 
a PfRACK (Madeira et al. 2003). Moreover 
functional genomics approaches show that 
PfRACK modulates Ca2+ signalling by inhibiting 
InsP3  evoked Ca2+ release in mammalian cells 
(Sartorello et al. 2009). PfRACK has also been 
identified in Maurer´s clefts indicating a role for 
the protein in signalling pathways within host cells 
(Garcia et al. 2008, Lanzer et al. 2006).
Another important Ca2+ modulated targets 
are the proteases. During the intraerytrocytic 
development the parasite alters the RBC plasma 
membrane and a variety of proteins are proteolyticaly 
processed (Wu et al. 2003, Garcia et al. 2008, Maier 
et al. 2009, Cruz et al. 2011, in press). Proteases have 
been shown to mediate the rupture of merozoites 
from RBC (Arastu-Kapur et al. 2008, Blackman 
2008), as well as protein trafficking by processing 
of the PEXEL motif in the endoplasmatic reticulum 
(Boddey et al. 2010, Russo et al. 2010) and degra-
dation of the erythrocyte cytoskeletal proteins 
through the calcium activated host protein calpain 1 
(Chandramohanadas et al. 2009).
Interestingly, calpains are cysteine proteases 
activated by calcium present in the host and the 
parasite. Phylogenetic analyses showed that many 
Plasmodium species has a calpain with homology 
on the N-terminal domain not found in the 
mammalian homology calpain (Russo et al. 2009, 
Wu et al. 2003). Interestingly the host calpain is 
involved in cytoskeletal remodeling (Goll et al. 
2003) and Plasmodium calpain-1 function has been 
related to parasite egress from erythrocyte whereas 
cysteine protease inhibitor blocked erythrocyte 
membrane disruption (Chandramohanadas et al. 
2009, Roiko and Carruthers 2009). Efforts to 
knockout the Plasmodium falciparum calpain was 
not successful, indicating the importance of this 
protease (Russo et al. 2009).
To illustrate Plasmodium intraerythrocitic cal-
cium signalling a putative model is shown in figure 1.
PARASITE LIGANDS AND ENDOTHELIAL RECEPTORS
The most notable parasite ligand for cytoadherence 
is P. falciparum erythrocyte membrane protein 1 
(PfEMP1), an antigenically diverse protein 
family that is expressed on the surface of knob-
like structures of mature IEs (Leech et al. 1984). 
PfEMP-1 varies within and between genetically 
identical parasite clones resulting in changes in 
their avidity for endothelial cell receptors. Other 
potential parasite ligands include Rifin, Stevor, 
modified Band 3 and Surfin that have been 
reviewed elsewhere (Rowe et al. 2009). Several 
endothelial surface receptors have been identified 
and characterised, including CD36 (Barnwell et al. 
1989, Ockenhouse et al. 1989) Thrombospondin 
(TSP) (Roberts et al. 1985), VCAM, E-selectin 
(Ockenhouse et al. 1992), P-selectin (Ho et al. 
1998), gC1qR (Biswas et al. 2007) and Intercellular 
adhesion molecule-1 (ICAM-1) (Berendt et al. 
1989). Both CD36 and ICAM-1 have been identi fied 
as receptors commonly mediating cytoadherence 
of patient derived Pf-IE (Newbold et al. 1997) 
and their effects in trigging and regulating signal 
transduction events have been well characterised; 
in this section we will review recent advances in 
cytoadherence and signalling which is illustrated 
by figure 2 showing the interface of Plasmodium 
falciparum infected erythrocyte (PRBC) and 
endothelial cell (EC).
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ICAM-1 MEDIATED ADHESION AND SIGNALLING
ICAM-1 is constitutively present on ECs but its 
expression is highly increased by pro-inflammatory 
cytokines such as interleukin-1 (IL-1), tumour 
necrosis factor (TNF) (Pober 2002). The stimulation 
of human vascular endothelial cells with Pf-IE 
resulted in the non-transient up-regulation of 
ICAM-1 expression on human ECs. The induction 
was independent of TNF (Esslinger et al. 1994) 
indicating that TNF-independent mechanisms (in 
addition to TNF-dependent) might exist in the 
pathogenesis of cerebral malaria (CM). The ability 
of Pf-IE to directly modulate EC depends on the 
avidity of IE for the receptors on host endothelium 
and is proportional to the level of activation of 
the signalling pathways, which usually requires 
direct physical contact (Chakravorty et al. 2007, 
Gray et al. 2003, Viebig et al. 2005). ICAM-1 
signalling occurs by receptor multimerization that 
is triggered when ligands bind in an ‘outside-in’ 
fashion. The ICAM-1 promoter contains several 
potential transcription factor binding sites, which 
have been implicated in induction of ICAM-1 
gene transcription in res ponse to various pro-
inflammatory stimuli (Muller et al. 1995, Ledebur 
and Parks 1995). It has been identified that the -187/-
178 on the ICAM-1 promoter is a NF-κB site, which 
is necessary and sufficient for rhinovirus activating 
ICAM-1 expression (Papi and Johnston 1999). 
Thrombin-induced ICAM-1 expression is also 
mediated by NF-κB activation via protease-activated 
receptor-1 (PAR-1), which induces binding of both 
p65/RelA and NFATc1 to the NF-κB binding site 
of ICAM-1 (Xue et al. 2009); the activation of  the 
JNK pathway likely involves Gαq, Gβγ, Ras, Rac1 
and Src family kinase (Miho et al. 2005). ICAM-1 
is a dynamic molecule that is localized in the apical 
membrane of the endothelium which clusters and 
aggregates upon binding to leukocyte ligands, such 
as LFA-1 (Grakoui et al. 1999). A similar process 
is involved in actin cytoskeleton rearrangement 
via Rho-like small GTPases family (Burridge and 
Wennerberg 2004). The cytoplasmic domain of 
ICAM-1 is composed of 28 amino acids (478-505): 
RQRKIKKYRLQQAQKGTPMKPNTQATPP 
(Carpen et al. 1992), this domain does not have 
intrinsic kinase activity or a Scr homologue domain 
that can recruit tyrosine-phosphorylated protein, 
but it does interact with actin-binding proteins, 
suggesting that ICAM-1 induced signalling may 
be initiated at the membrane-cytoskeleton interface 
(Vogetseder and Dierich 1991). ICAM-1 ligation 
or clustering at the cell surface leads to a range 
of signalling-mediated activities through cascades 
involving a number of kinases including p38 MAPK 
(Mitogen-activated protein kinases)-inducing heat-
shock protein 27 phosphorylation in pulmonary 
microvascular ECs, which in turn modulates 
cytoskeletal rearrangements and neutrophil 
migration toward EC junctions (Wang et al. 2002). 
The tyrosine phosphorylation of cytoskeletal 
proteins, focal adhesion kinase, paxillin, and p130 
in cerebral ECs were mediated by Rho activation 
(Etienne et al. 1998). Experimental cerebral 
malaria (ECM) infected with P. berghei ANKA 
(PbA) in C57BL/6J mice (which has virtually no 
IE sequestration in the brain but shares features of 
vessel occlusion and inflammation) has revealed 
the activation of all key elements in the JNK 
pathway such as p-MKK4, p-JNK and p-c-Jun in 
mice brains (Anand and Babu 2011). JNK not only 
caused c-Jun phosphorylation but also affected the 
activities of multiple proteins such as ATF2, P53, 
Elk1 c-Myc and bcl-2 family relating to apoptosis 
(Liu and Lin 2005), indicating that these pathways 
and components played critical roles in mediating 
neuronal cell death during ECM.
The regulation of EC due to P. falciparum 
cytoadherence is seen at the transcriptional level, 
using microarray analysis of HUVEC transcriptome 
following in vitro co-culture of IE and HUVEC. 
This showed significant differential regulation of 
genes which defined gene ontologies such as cell 
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communication, cell adhesion, signal transduction 
and immune response (Chakravorty et al. 2007). 
The investigation of global gene responses of 
human brain microvascular endothelial cells 
(HBMEC) after the interaction with Pf-IE resulted 
in the similar results and  more specifically, several 
members of NF-κB signalling cascade was induced 
with 4 of 5 NF-κB subunits (REL-B, cREL, NF-κB1 
and NF-κB2) up-regulated together with significant 
increase of NF-κB target genes. It was found that 
one of the NF-κB family members, REL-1A (P65) 
almost completely translocated into the nuclear 
compartment within 10 min of IE-EC interaction, 
suggesting a direct role for parasite factors in NF-
κB activation (Tripathi et al. 2009). ICAM-1 was 
significantly increased upon IE interaction EC and 
there was a correlation between adherent IEs with 
this increased level. The interacting IE induced a 
730% increase in ICAM-1 on HBMEC; two NF-κB 
inhibitors, Bay11-7082 and MG132, were able to 
reduce IE-induced ICAM-1 up-regulation, Bay11-
7082 completely abolished IE-induced ICAM-1 
expression at a concentration of 40mM (Tripathi 
et al. 2006). An antioxidant and NF-κB indirect 
inhibitor, pyrrolidine dithiocarbamate (PDTC), 
which acts by removing the reactive oxygen species 
(ROS) intermediates, also had similar functions 
indicating that ROS may also involved in IE-EC 
ICAM-1 signalling as IEs can generate a wide 
variety of ROS (Atamna et al. 1994, Ginsburg 
and Atamna 1994). How IE are activating NF-
κ-B in EC is not clear. Possibily, P. falciparum-
derived glycosylphosphatidylinositol (PfGPI) toxin 
activates vascular endothelial cells by tyrosine kinase 
mediated signal transduction, leading to NFκB/c-rel 
activation (Schofield et al. 1996). Specific MAPK 
pathways have been linked to severe malaria 
through work on the response of macrophages to 
PfGPI, normally resulting in TNF secretion. A JNK 
inhibitor alleviated phosphorylation of a number 
of signalling molecules, and reduced amount of 
TNF secreted by PfGPI-stimulated macrophages 
(Tachado et al. 1996, 1997). More evidence has 
demonstrated that NF-κB is essential for ICAM-1 
expression induced by inflammatory cytokines 
(Ledebur and Parks 1995) and neutrophil adhesion 
(Rahman et al. 1999). The mechanism of NF-κB 
activation via a variety of extracellular stimuli is 
unique in that it is induced rapidly and does not 
require de novo protein synthesis, thereby allowing 
cells to respond quickly to emergent situations, 
such as bacterial infection.
CD36 MEDIATED CYTOADESION AND SIGNALLING
CD36 is expressed on the EC surface and binds to 
many ligands such as collagen, thrombospondin, 
oxidized low density lipoprotein, native 
lipoproteins, oxidized phospholipids and long-
chain fatty acids (Tandon et al. 1989, Silverstein 
et al. 1992, Endemann et al. 1993, Nicholson et al. 
1995, Calvo et al. 1998, Podrez et al. 2002). CD36 
has been shown to be a major sequestration receptor 
on microvascular endothelial cells. In P. falciparum 
malaria, CD36 has long been considered a major 
contributor to pathogenesis by acting as a vascular 
receptor for the adhesion of IE (Ho and White 1999). 
It is thought that CD36 is involved in the PfGPI 
induced MAPK activation and proinflammatory 
cytokine secretion, and has been shown to have a 
role in the innate immune response to malaria in 
mouse models. Protein kinase C (PKC)–dependent 
sequence RGPYTYRVRFLA is a target of Thr92 
phosphorylated CD36 in endothelium (Daviet and 
Mcgregor 1997), and there is minimal binding 
domain with 179-amino-acid peptide located 
in exon 1 of PfEMP-1 that anchors CD36 and 
induces an intracellular signal (Yipp et al. 2003b). 
In an immunohistochemistry study examining the 
distribution of sequestration receptors in different 
organs from fatal cases of P. falciparum malaria and 
non-infected controls, fatal malaria was associated 
with significantly higher levels of ICAM-1 and 
E-selectin expression on vessels in the brain, as 
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well as CD36, but CD36 and thrombospondin 
staining were thinly scattered in this tissue (Turner 
et al. 1994). Adhesion receptors have co-operative 
functions that contribute to cytoadherence. As shown 
by single-molecule force spectroscopy technique, 
both CD36 and TSP are involved in specific ligand-
receptor interactions, but CD36-mediated signal 
molecule interactions were more stable than TSP, 
although the TSP-IE interaction was stronger than 
the CD36-IE interaction in the high pulling rate 
regime, indicating that TSP mediated interactions 
may initiate cytoadhesion whereas CD36 might 
function to stabilise binding (Li et al. 2011). 
ICAM-1 and CD36 have been shown in ex vivo 
binding assays to synergize to mediate adherence 
of Pf-IE to cultured human microvascular EC 
(Mccormick et al. 1997). It has also been reported 
that cytoadhesion of CSA-binding IEs on EC can 
inhibit the cytoadhesion of CD36-binding IEs, 
which is mediated by a CD44-transduced signal on 
SBEC-1D (Saimiri sciureus brain EC) cells. Two 
elements from signal transduction pathways Src-
kinase and MAP-kinase were identified downstream 
of CD44 receptor (Jurzynski et al. 2007).
The mechanisms of intracellular signalling 
events have been studied extensively using parallel 
plate flow chamber in vitro assays or in intact 
human microvessels in a human/severe combined 
immunodeficient (SCID) mouse model in vivo. 
These have demonstrated major roles for CD36 
in IE cytoadherence on microvascular endothelial 
cells. A recombinant peptide corresponding to the 
minimal CD36-binding domain in PfEMP1 can 
inhibit and even reverse the IE adhesion of clinical 
isolates, and an anti-CD36 monoclonal antibody 
can inhibit IE binding both in vitro and in vivo 
(Yipp et al. 2003a). ICAM-1 appears to stabilize 
the IE-CD36 interaction without an increase in the 
number of IE recruited to the endothelium, while 
the induction of P-selectin can increase the number 
of rolling IEs which subsequently adhere to CD36 
(Ho et al. 2000). Treatment of HDMECs with a 
Src-family kinase-selective inhibitor (PP1) resulted 
in a significant reduction of IE adhesion by 72% 
in a flow-chamber assay. The effect of PP1 could 
be mimicked by a specific alkaline-phosphatase 
inhibitor levamisole. These results pointed to the 
use of inhibitors for Src-family kinases and ecto-
alkaline phosphatase  therapeutically (see below) 
(Yipp et al. 2003a). Binding of IE to HDMEC also 
resulted in the downstream activation of the MAPK 
pathway, but inhibition of the extracellular signal-
regulated kinase 1/2 (ERK 1/2) and p38 MAP 
kinase pathways had no immediate effect on IE 
adhesion, although the mitogen-activated protein 
(MAP) kinase pathway activation was Src-family 
kinase dependent. NIH 3T3 cells transfected with 
wild-type CD36 or a mutant protein in which Thr92 
was substituted by Ala were used as a model to 
support the rolling and adhesion of IEs under flow 
conditions. It was also shown that the target of the 
alkaline phosphatase is the ectodomain of CD36 at 
threonine-92 (Thr92), and this regulated IE adhesion 
to CD36 under flow conditions in a Src family 
kinase and alkaline phosphatase dependent manner. 
A molecular mechanism underlying IE-CD36 
binding has been proposed: CD36 is constitutively 
phosphorylated; upon initial IE adhesion and 
subsequent Src family kinase activation, CD36 
becomes dephosphorylated through the activation of 
an ecto-alkaline phosphatase, which is expressed on 
the surface of endothelial cells.  Dephosphorylated 
CD36 binds to IE with higher affinity than to 
phosphorylated CD36 (Ho et al. 2005).
SIGNALLING INSIDE IEs
Sicard et al have shown that P. falciparum infection 
induced modulation of the host PAK1→MEK1 
pathway and the pharmacological interference 
with this pathway using highly specific allosteric 
inhibitors of human PAK and MEK enzymes 
caused a block of parasite proliferation in both liver 
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and blood stages of parasites (Sicard et al. 2011). 
The role of signalling in Pf-IE has not been studied 
extensively in relation to cytoadherence except for 
one study on casein kinase inhibition and its effect 
on adhesion (Hora et al. 2009).
Extracellular domains of PfEMP1 are variable 
and bind various host endothelial receptors, 
whereas their cytoplasmic domains (VARCs) are 
relatively conserved with binding affinity to P. 
falciparum knob-associated histidine-rich protein 
(KAHRP). The interaction of VARC and KAHRP 
was affected by PfEMP1 phosphorylation on 
VARC and was considered as an important 
parameter in cytoadherence. By using specific 
inhibitors and enhancers, an enzyme responsible 
for VARC phosphorylation has been identified as 
erythrocytic casein kinase II (CKII) and a set of 
cell-permeable CKII inhibitors have been tested 
on cytoadhesion of IEs to soluble EC receptors. 
These inhibitors possibly block or reverse the 
interaction between VARC and its binding partners, 
and so have the ability to reduce cytoadherence 
and could be considered in the development of 
therapies against severe malaria.
CYTOADHERENCE OF P. FALCIPARUM MEDIATED BY PLATELETS
Increasing evidence shows that platelets may be 
involved in CM pathogenesis. Platelets have recently 
been shown to accumulate in brain microvessels 
of patients with CM and to modulate the binding 
of P. falciparum-infected red cells to human brain 
endothelium in vitro (Wassmer et al. 2006a). Several 
groups have suggested that platelet-mediated 
clumping of IEs to form apparent auto-agglutinates 
is a common adhesive phenotype in severe malaria 
(Wassmer et al. 2008, Mayor et al. 2011) although 
others have questioned this (Arman et al. 2007). Using 
a platelet-endothelial cell co-culture model, Wassmer 
et al. 2006b have investigated the mechanisms by 
which platelets modify the function of HBMEC, and 
have found that platelets have a pro-apoptotic effect 
on TNF-activated HBMEC in a contact-dependent 
manner and the supernatants of thrombin-activated 
platelets killed TNF-stimulated HBMEC. TGF-1 was 
found as a major molecule involved in endothelial 
cell death (Wassmer et al. 2006b), which could be a 
mechanism of microvascular damage during human 
CM. The interaction of P. falciparum with platelets 
might also lead to platelet activation and release of 
inflammatory mediators such as platelet factor 4 
(PF4)/CXCL4 by moderating the effects of heparin-
like molecules on ECs (Srivastava et al. 2008). 
However, purified human platelets killed cultured 
P. falciparum IE and platelet-deficient or aspirin-
treated mice were more susceptible to death during 
P. chabaudi infection, indicated the protective 
aspect of platelets in early stage of erythrocytic 
infection (Mcmorran et al. 2009). Several EC 
receptors are likely responsible for platelet-mediated 
IE cytoadhesion including P-selectin (CD62P) 
(Udomsangpetch et al. 1997); Thrombospondin 
(TSP) (Roberts et al. 1985); Platelet endothelial 
cell adhesion molecule 1 (PECAM1 or CD31) 
(Treutiger et al. 1997, Heddini et al. 2001), globular 
C1q receptor (gC1qR/ HABP1/p32) (Biswas et al. 
2007) and CD36 (Pain et al. 2001). It has also been 
shown that platelets expressing CD36 serve as a 
bridge to bind IEs via PfEMP1 to the endothelial 
cell membrane either directly (Wassmer et al. 2004) 
or through ultra-large von Willebrand factor strings 
(Bridges et al. 2010).
The transcriptional changes of HBMEC in 
response to platelets in the presence or the absence 
of TNF and IEs have been analyzed by Barbier et 
al. 2011. The platelets induced the expression of 
genes involved in inflammation and apoptosis and 
altered canonical pathways such as chemokines, 
TGFβ, death-receptors, erythropoietin and 
TREM1-signalling (Barbier et al. 2011), supporting 
the hypothesis that platelets play a pathogenic 
role in CM.  The platelet mediated cytoadhesion 
also involved the activation of Weibel-Palade 
(WP) bodies and release of von Willebrand factor 
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(VWF) (Hollestelle et al. 2006).  Released VWF 
is in an activated conformation that could interact 
with platelet receptor gpIa/V/IV and trigger 
intravascular platelet aggregation (Groot et al. 
2007). Ultra-large VWF multimers are ‘unfurled’ 
under flow, presenting a highly adherent platform 
for platelet recruitment and subsequent IE adhesion 
via platelet-expressed CD36. Induction of this 
pathway in vitro is very rapid with significant levels 
of VWF available for platelet adhesion within 
minutes of WP body activation, making this an 
attractive mechanism for efficient cytoadherence 
early in infection. Interestingly, such an IE pro-
adhesive state can be removed through the action 
of the VWF protease ADAMTS-13 (a disintegrin 
and metalloproteinase with a thrombospondin type 
1 motif, member 13) that rapidly clears ultra-large 
VWF on ECs (Dong et al. 2002), but activity of this 
enzyme is reduced in severe malaria (De Mast et al. 
2009, Larkin et al. 2009, Lowenberg et al. 2010).
CYTOADHERENCE INHIBITION VIA SIGNAL 
TRANSDUCTION PATHWAYS
The importance of signal transduction in Plasmodium 
infection has been also obtained using known 
inhibitors of the signalling system. Many of these 
inhibitors are drugs already in clinical use, which 
makes them more feasible as therapeutic agents 
in anti-malaria regimes. For example, the in vitro 
anti-plasmodial activity of  antioxidant compounds, 
Flavonoids, from Artemisia annua L has recently 
been reported as protein kinases inhibitor that able to 
several kinases including Akt/protein kinase B (Akt/
PKB), Fyn, Janus kinase 1 (JAK1), mitogen-activated 
protein kinase kinase 1 (MEK1), phosphoinositide 
3-kinase (PI3K), mitogen-activated protein (MAP) 
kinase, kinase 4 (MKK4), Raf1, and zeta chain-
associated 70-kDa protein (ZAP-70) kinase (Hou 
and Kumamoto 2010). Artemisinin has also been 
shown to inhibit nuclear translocation of NF-кB 
complex (Aldieri et al. 2003).
Levamisole is a specific alkaline-phosphatase 
inhibitor, has been shown in vitro to inhibit of 
sequestration of Pf-IE to endothelium. It has been 
used in a pilot clinical study for uncomplicated 
malaria, which resulted in increased peripheral 
blood parasitaemia of mature P. falciparum 
IE 24 hours after Levamisole administration. 
The sequestration ratio (between observed and 
expected peripheral blood parasitaemia) of early 
trophozoite and midtrophozoite parasites increased 
after Levamisole treatment, with near complete 
prevention of early trophozoites sequestration and 
>65% prevention of mid-trophozoite sequestration. 
These findings strongly suggest that levamisole 
decreases iRBC sequestration in P. falciparum 
malaria in vivo (Dondorp et al. 2007). Such an 
inhibitor for ecto-alkaline phosphatase could be 
exploited therapeutically although it may work 
through other mechanisms such inhibition of ion 
channel blockade and platelet aggregation (Mun 
et al. 1998). Levamisole could enhance immune 
response towards T helper 1 development through the 
activation of dendritic cells or T cell aspects (Chen 
et al. 2008). It has been reported that Levamisole 
inhibited rat platelet aggregation by releasing of a 
prostacyclin-like factor in vivo (Pinto et al. 1990).
Recently a rho-kinase inhibitor Fasudil, a 
drug already in clinical use for cardio- and neuro-
vascular diseases, was successfully tested on 
laboratory strains of P. falciparum using an in vitro 
co-culture model. It was shown that adhesion of IE 
to primary human lung endothelial cells (HLECs) 
activated the Rho kinase signalling pathway, which 
led to endothelial barrier permeabilization. When 
Fasudil was added concomitantly with IE, this 
decreased both NF-κB activation and endothelial 
cell apoptosis. Fasudil also helped to restore 
endothelial barrier integrity after IE adhesion.  Rho 
kinase inhibition thus appears to be a promising 
adjunctive therapeutic agent for severe malaria 
(Taoufiq et al. 2008). Fasudil was also tested in 
patient isolates at schizont stage in contact and non-
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contact experiments with HLEC. In both conditions, 
30 µM Fasudil significantly reduced P. falciparum-
mediated HLEC apoptosis after 24 hours, but 
it did not decrease significantly P. falciparum 
cytoadherence (Zang-Edou et al. 2010, Waknine-
Grinberg et al. 2010).  It has been reported that the 
anti-inflammatory effect of the Rho kinase inhibitor 
fasudil was via inhibition of NF-κB activation in 
rheumatoid arthritis (Okamoto et al. 2010).
Atorvastatin is a cholesterol-lowering medi-
cation and is widely used in patients with 
cardiovascular disorders.  It has been shown that 
atorvastatin protected EC from senescence and 
apoptosis. The molecular mechanism of this 
protection is correlated with the activation of the 
anti-apoptotic inositol triphosphate (PI3)-Akt 
kinase pathway, resulting in the phosphorylation 
of endothelial nitric oxide synthase (Kureishi et 
Figure 1. Schematic model for calcium signalling in intraerythrocitic stages of Plasmodium. Calcium 
signalling in intraerythrocitic stages of Plasmodium. Melatonin (Mel) binds a putative receptor (R) at 
the parasite membrane (PM), leading to the activation of a phospholipase C (PLC), which generates 
the second messengers diacylglycerol (DAG) and inositol 1,4,5 triphosphate (IP3). IP3 binds to 
putative IP3 receptors (IP3R) located at the membrane of the endoplasmic reticulum (ER), leading 
to the release of calcium (Ca2+). Ca2+ rise in the parasite cytosol is responsible for the activation 
of numerous downstream effectors, as calmodulin (cAM), calcium-dependent protein kinases 
(CDPKs) and proteases, as well as generating further Ca2+ increase in the cytosol via influx from 
the plasma membrane, a process known as capacitative calcium entry (CCE). Ca2+ may also enter 
the mitochondria (Mit), activating its metabolism. Ca2+ is also able to induce an increase in cyclic 
adenosine monophosphate (cAMP) in the cytosol, whose production is regulated by adenylyl cyclase 
(AC) and phosphodiesterase (PDE). cAMP is able to promote further calcium increase from the 
ER. Besides the ER, calcium is also stocked in intracellular acidic pools (AC). The parasitophorous 
vacuole is a milieu rich in Ca2+. Adenosine triphosphate (ATP) is able to induce calcium influx from 
the external milieu via putative purinergic-like receptors. Guanylate cyclase (GC) activity, which 
leads to the production of cyclic guanosine monophosphate (cGMP) is also implicated in cell cycle 
signalling to initiate gametogenesis and progression of schizogony. EM: erythrocyte membrane, 
PVM: parasitophorous vacuole membrane.
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al. 2000). Atorvastatin decreases ICAM-1 expres-
sion in stimulated EC and monocytes (Romano 
et al. 2000). The roles of atorvastatin in the 
activation of cell survival protein kinase B or Akt 
signalling pathway is well established (Mason 
2003, Wolfrum et al. 2003). The rho-kinase 
pathway in many aspects is antagonistic to PI3K/
Akt/eNOS endothelial cell survival pathway 
(Zhou and Liao 2009). Recently, co-culture using 
mature P. falciparum 3D7 and primary HLEC IE-
induced increased levels of endothelial adhesion 
molecules, ICAM-1 and P-selectin.  Pre-treatment 
of EC with atorvastatin significantly prevented 
this up-regulation, protected endothelial cells from 
IE-induced apoptosis and protected endothelial 
barrier integrity from IE-induced impairment. The 
increased Akt expression in HLEC exposed to IE 
was observed by both Western blot and confocal 
microscopy techniques (Taoufiq et al. 2011).
CONCLUSIONS
Taken together Ca2+ mediated signalling offers 
potentials new molecular targets for the development 
of novel antimalarial. Several studies have explored 
the possibilities of using existing medications as 
therapeutic modalities to reduce IE sequestration 
e.g. Src-family kinases, ecto-alkaline phosphatase, 
rho-kinase and AKT activator. However, the 
regulation of signalling pathways is complicated 
and results are difficult to interpret due to the 
interconnection of different signalling pathways via 
protein networks which are controlled by multiple 
positive and negative feedback mechanisms.  Some 
pathways in certain situation may be redundant, 
some activation may only be transient and some 
key components of pathways could often be shared 
by multiple signalling cascades. More elegant 
methods and techniques are needed to elucidate the 
molecular mechanism mediating cytoadhesion and 
thereby find the key issues in these for the design of 
new therapies to control disease.
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RESUMO
A Malária é responsavel por mais de 1.5 milhões de 
mortes anualmente, especialmente entre crianças (Snow 
et al. 2005). Apesar da gravidade da situação e grande 
esforço para o desenvolvimento de novas drogas (Yuan et 
al. 2011), os investimentos em drogas antimaláricas ainda 
é relativamente baixo. Brevemente, os alvos antimaláricos 
atualmente testados incluem: quinases, proteases, canais 
iônicos para GPCR, receptores nucleares entre outros 
(Gamo et al. 2010). No presente trabalho nós revisamos 
as vias de transdução de sinal em eritrócitos assim como 
eritrócitos infectados e interações com células endoteliais, 
denominada citoaderência. Este processo é conhecido 
por sua importante função na patogenicidade da malária 
severa. As moléculas expressas na superfície dos 
Figure 2. Summary figure for cytoadherence linked signalling 
showing interface of Plasmodium falciparum infected erythrocyte 
(PRBC) and endothelial cell (EC). 
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eritrócitos infectados (IE) e células endoteliais vasculares 
(EC) são importantes mediadores da citoaderência, não 
apenas induzindo mudanças estruturais e metabólicas nos 
dois lados, mas também desencadeiam diversos sinais do 
processo transducional, levando a alteração da expressão 
gênica, com o balanço entre a regulação positiva e 
negativa determinando a patologia endotelial durante a 
infecção malárica.
Palavras-chave: citoaderência, eritrócito, malária, 
Plasmodium, transdução de sinal.
REFERENCES
AKKAYA C, SHUMILINA E, BOBBALLA D, BRAND VB, MAHMUD
H, LANG F AND HUBER SM. 2009. The Plasmodium 
falciparum-induced anion channel of human erythrocytes 
is an ATP-release pathway. Pflugers Arch 457: 1035-1047.
ALDIERI E, ATRAGENE D, BERGANDI L, RIGANTI C, COSTAMAGNA
C, BOSIA A AND GHIGO D. 2003. Artemisinin inhibits 
inducible nitric oxide synthase and nuclear factor NF-kB 
activation. FEBS Lett  552: 141-144.
ALESSI DR, ANDJELKOVIC M, CAUDWELL B, CRON P, MORRICE
N, COHEN P AND HEMMINGS BA. 1996. Mechanism 
of activation of protein kinase B by insulin and IGF-1. 
EMBO J 15: 6541-6551.
ALVES E, BARTLETT PJ, GARCIA CR AND THOMAS AP. 2010.
Melatonin and IP3-induced Ca2+ release from 
intracellular stores in the malaria parasite Plasmodium 
falciparum within infected red blood cells. J Biol Chem 
286: 5905-5912.
ANAND SS AND BABU PP. 2011. c-Jun N terminal kinases (JNK)
are activated in the brain during the pathology of 
experimental cerebral malaria. Neurosci Lett 488: 118-122.
ANDJELKOVIC M, ALESSI DR, MEIER R, FERNANDEZ A, LAMB
NJ, FRECH M, CRON P, COHEN P, LUCOCQ JM AND 
HEMMINGS BA. 1997. Role of translocation in the 
activation and function of protein kinase B. J Biol Chem 
272: 31515-31524.
ARASTU-KAPUR S, PONDER EL, FONOVIC UP, YEOH S, YUAN F,
FONOVIC M, GRAINGER M, PHILLIPS CI, POWERS JC AND 
BOGYO M. 2008. Identification of proteases that regulate 
erythrocyte rupture by the malaria parasite Plasmodium 
falciparum. Nat Chem Biol 4: 203-213.
ARMAN M, RAZA A, TEMPEST LJ, LYKE KE, THERA MA, KONE
A, PLOWE CV, DOUMBO OK AND ROWE JA. 2007. Platelet-
mediated clumping of Plasmodium falciparum infected 
erythrocytes is associated with high parasitemia but 
not severe clinical manifestations of malaria in African 
children. Am J Trop Med Hyg 77: 943-946.
ATAMNA H, PASCARMONA G AND GINSBURG H. 1994. Hexose-
monophosphate shunt activity in intact Plasmodium 
falciparum-infected erythrocytes and in free parasites. 
Mol Biochem Parasitol  67: 79-89.
BAGNARESI P, ALVES E, DA SILVA HB, EPIPHANIO S, MOTA MM
AND GARCIA CR. 2009. Unlike the synchronous 
Plasmodium falciparum and P. chabaudi infection, the 
P. berghei and P. yoelii asynchronous infections are not 
affected by melatonin. Int J Gen Med 2: 47-55.
BARBIER M ET AL. 2011. Platelets alter gene expression profile
in human brain endothelial cells in an in vitro model of 
cerebral malaria. PLoS One 6: e19651.
BARNWELL JW, ASCH AS, NACHMAN RL, YAMAYA M, AIKAWA
M AND INGRAVALLO P. 1989. A human 88-kD membrane 
glycoprotein (CD36) functions in vitro as a receptor for a 
cytoadherence ligand on Plasmodium falciparum-infected 
erythrocytes. J Clin Invest 84: 765-772.
BERALDO FH, ALMEIDA FM, DA SILVA AM AND GARCIA CR. 
2005. Cyclic AMP and calcium interplay as second 
messengers in melatonin-dependent regulation of 
Plasmodium falciparum cell cycle. J Cell Biol 170: 551-557.
BERALDO FH, MIKOSHIBA K AND GARCIA CR. 2007. Human
malarial parasite, Plasmodium falciparum, displays 
capacitative calcium entry: 2-aminoethyl diphenylborinate 
blocks the signal transduction pathway of melatonin action 
on the P. falciparum cell cycle. J Pineal Res 43: 360-364.
BERENDT AR, SIMMONS DL, TANSEY J, NEWBOLD CI AND
MARSH K. 1989. Intercellular adhesion molecule-1 is 
an endothelial cell adhesion receptor for Plasmodium 
falciparum. Nature 341: 57-59.
BILLKER O, DECHAMPS S, TEWARI R, WENIG G, FRANKE-FAYARD
B AND BRINKMANN V. 2004. Calcium and a calcium-
dependent protein kinase regulate gamete formation and 
mosquito transmission in a malaria parasite. Cell 117: 503-514.
BISWAS AK, HAFIZ A, BANERJEE B, KIM KS, DATTA K AND
CHITNIS CE. 2007. Plasmodium falciparum uses gC1qR/
HABP1/p32 as a receptor to bind to vascular endothelium and 
for platelet-mediated clumping. PLoS Pathog 3: 1271-1280.
BLACKMAN MJ. 2008. Malarial proteases and host cell egress:
an 'emerging' cascade. Cell Microbiol 10: 1925-1934.
BODDEY JA ET AL. 2010. An aspartyl protease directs malaria
effector proteins to the host cell. Nature 463: 627-631.
BRIDGES DJ, BUNN J, VAN MOURIK JA, GRAU G, PRESTON RJ,
MOLYNEUX M, COMBES V, O'DONNELL JS, DE LAAT B AND 
CRAIG A. 2010. Rapid activation of endothelial cells enables 
Plasmodium falciparum adhesion to platelet-decorated von 
Willebrand factor strings. Blood 115: 1472-1474.
BUDU A, PERES R, BUENO VB, CATALANI LH AND GARCIA CR.
2007. N1-acetyl-N2-formyl-5-methoxykynuramine mo-
du-lates the cell cycle of malaria parasites. J Pineal Res 
42: 261-266.
BURRIDGE K AND WENNERBERG K. 2004. Rho and Rac take
center stage. Cell 116: 167-179.
CALVO D, GOMEZ-CORONADO D, SUAREZ Y, LASUNCION MA
AND VEGA MA. 1998. Human CD36 is a high affinity 
receptor for the native lipoproteins HDL, LDL, and 
VLDL. J Lipid Res 39: 777-788.
CARLTON JM ET AL. 2008. Comparative genomics of the
neglected human malaria parasite Plasmodium vivax. 
Nature 455: 757-763.
An Acad Bras Cienc (2012) 84 (2)
567PLASMODIUM-RBC INTERACTIONS AND CYTOADHERENCE
CARPEN O, PALLAI P, STAUNTON DE AND SPRINGER TA. 1992.
Association of intercellular adhesion molecule-1 (ICAM-1) 
with actin-containing cytoskeleton and alpha-actinin. J 
Cell Biol 118: 1223-1234.
CHAKRAVORTY SJ, CARRET C, NASH GB, IVENS A, SZESTAK
T AND CRAIG AG. 2007. Altered phenotype and gene 
transcription in endothelial cells, induced by Plasmodium 
falciparum-infected red blood cells: pathogenic or 
protective? Int J Parasitol 37: 975-987.
CHAKRAVORTY SJ, HUGHES KR AND CRAIG AG. 2008. Host
response to cytoadherence in Plasmodium falciparum. 
Biochem Soc Trans 36: 221-228.
CHANDRAMOHANADAS R, DAVIS PH, BEITING DP, HARBUT MB,
DARLING C, VELMOUROUGANE G, LEE MY, GREER PA, 
ROOS DS AND GREENBAUM DC. 2009. Apicomplexan 
parasites co-opt host calpains to facilitate their escape 
from infected cells. Science 324: 794-797.
CHEN LY, LIN YL AND CHIANG BL. 2008. Levamisole enhances
immune response by affecting the activation and 
maturation of human monocyte-derived dendritic cells. 
Clin Exp Immunol 151: 174-181.
CHEN S, DELL EJ, LIN F, SAI J AND HAMM HE. 2004. RACK1
regulates specific functions of Gbetagamma. J Biol Chem 
279: 17861-17868.
CLARK IA, BUDD AC, ALLEVA LM AND COWDEN WB. 2006.
Human malarial disease: a consequence of inflammatory 
cytokine release. Malar J 5: 85.
COPPI A, TEWARI R, BISHOP JR, BENNETT BL, LAWRENCE R,
ESKO JD, BILLKER O AND SINNIS P. 2007. Heparan sulfate 
proteoglycans provide a signal to Plasmodium sporozoites 
to stop migrating and productively invade host cells. Cell 
Host Microbe 2: 316-327.
CRUZ LN, ALVES E, LEAL MT, JULIANO MA, ROSENTHAL PJ,
JULIANO L AND GARCIA CR. 2011. FRET peptides reveal 
differential proteolytic activation in intraerythrocytic 
stages of the malaria parasites Plasmodium berghei and 
Plasmodium yoelii. Int J Parasitol 41: 363-372.
CRUZ LN, JULIANO MA, BUDU A, JULIANO L, HOLDER AA,
BLACKMAN MJ AND GARCIA CR. In press. Extracellular ATP 
triggers proteolysis and cytosolic Ca2+ rise in Plasmodium 
berghei and Plasmodium yoelii malaria parasites. Malar J.
DAVIET L AND MCGREGOR JL. 1997. Vascular biology of CD36:
roles of this new adhesion molecule family in different 
disease states. Thromb Haemost 78: 65-69.
DE MAST Q ET AL. 2009. ADAMTS13 deficiency with elevated
levels of ultra-large and active von Willebrand factor 
in P. falciparum and P. vivax malaria. Am J Trop Med 
Hyg 80: 492-498.
DE RASMO D, PANELLI D, SARDANELLI AM AND PAPA S. 2008.
cAMP-dependent protein kinase regulates the 
mitochondrial import of the nuclear encoded NDUFS4 
subunit of complex I. Cell Signal 20: 989-997.
DOERIG C ET AL. 2010. Malaria: targeting parasite and host cell
kinomes. Biochim Biophys Acta 1804: 604-612.
DONDORP AM, SILAMUT K, CHARUNWATTHANA P,
CHUASUWANCHAI S, RUANGVEERAYUT R, KRINTRATUN S, 
WHITE NJ, HO M AND DAY NP. 2007. Levamisole inhibits 
sequestration of infected red blood cells in patients with 
falciparum malaria. J Infect Dis  196: 460-466.
DONG JF, MOAKE JL, NOLASCO L, BERNARDO A, ARCENEAUX
W, SHRIMPTON CN, SCHADE AJ, MCINTIRE LV, FUJIKAWA 
K AND LOPEZ JA. 2002. ADAMTS-13 rapidly cleaves 
newly secreted ultralarge von Willebrand factor multimers 
on the endothelial surface under flowing conditions. Blood 
100: 4033-4039.
ENDEMANN G, STANTON LW, MADDEN KS, BRYANT CM, WHITE
RT AND PROTTER A A. 1993. CD36 is a receptor for oxidized 
low density lipoprotein. J Biol Chem 268: 11811-11816.
ESSLINGER CW, PICOT S AND AMBROISE-THOMAS P. 1994. Intra-
erythrocytic Plasmodium falciparum induces up-
regulation of inter-cellular adhesion molecule-1 on human 
endothelial cells in vitro. Scand J Immunol 39: 229-232.
ETIENNE S, ADAMSON P, GREENWOOD J, STROSBERG AD,
CAZAUBON S AND COURAUD PO. 1998. ICAM-1 signaling 
pathways associated with Rho activation in microvascular 
brain endothelial cells. J Immunol 161: 5755-5761.
FARIAS SL, GAZARINI ML, MELO RL, HIRATA IY, JULIANO MA,
JULIANO L AND GARCIA CR. 2005. Cysteine-protease 
activity elicited by Ca2+ stimulus in Plasmodium. Mol 
Biochem Parasitol 141: 71-79.
FLECK SL ET AL. 2003. Suramin and suramin analogues inhibit
merozoite surface protein-1 secondary processing and 
erythrocyte invasion by the malaria parasite Plasmodium 
falciparum. J Biol Chem 278: 47670-47677.
GAMO FJ ET AL. 2010. Thousands of chemical starting points
for antimalarial lead identification. Nature 465: 305-310.
GARCIA CR, DE AZEVEDO MF, WUNDERLICH G, BUDU A,
YOUNG JA AND BANNISTER L. 2008. Plasmodium in the 
postge nomic era: new insights into the molecular cell biology 
of malaria parasites. Int Rev Cell Mol Biol 266: 85-156.
GAZARINI ML, BERALDO FH, ALMEIDA FM, BOOTMAN M, DA
SILVA AM AND GARCIA CR. 2011. Melatonin triggers PKA 
activation in the rodent malaria parasite Plasmodium 
chabaudi. J Pineal Res 50: 64-70.
GAZARINI ML AND GARCIA CR. 2004. The malaria parasite
mitochondrion senses cytosolic Ca2+ fluctuations. 
Biochem Biophys Res Commun 321: 138-144.
GINSBURG H AND ATAMNA H. 1994. The redox status of malaria-
infected erythrocytes: an overview with an emphasis on 
unresolved problems. Parasite 1: 5-13.
GOLL DE, THOMPSON VF, LI H, WEI W AND CONG J. 2003. The
calpain system. Physiol Rev 83: 731-801.
GRAKOUI A, BROMLEY SK, SUMEN C, DAVIS MM, SHAW AS,
ALLEN PM AND DUSTIN ML. 1999. The immunological 
synapse:a molecular machine controlling T cell activation. 
Science 285: 221-227.
GRAY C, MCCORMICK C, TURNER G AND CRAIG A. 2003. ICAM-1
can play a major role in mediating P. falciparum adhesion to 
endothelium under flow. Mol Biochem Parasitol 128: 187-193.
An Acad Bras Cienc (2012) 84 (2)
568 LAURA N. CRUZ,YANG WU, ALISTER G. CRAIG and CÉLIA R.S. GARCIA
GROOT E, DE GROOT PG, FIJNHEER R AND LENTING PJ. 2007.
The presence of active von Willebrand factor under various 
pathological conditions. Curr Opin Hematol 14: 284-289.
HALL N ET AL. 2005. A comprehensive survey of the Plasmodium
life cycle by genomic, transcriptomic, and proteomic 
analyses. Science 307: 82-86.
HARPER JF AND HARMON A. 2005. Plants, symbiosis and parasites:
a calcium signaling connection. Nat Rev Mol Cell Biol 
6: 555-566.
HEDDINI A, CHEN Q, OBIERO J, KAI O, FERNANDEZ V, MARSH
K, MULLER WA AND WAHLGREN M. 2001. Binding of 
Plasmodium falciparum-infected erythrocytes to soluble 
platelet endothelial cell adhesion molecule-1 (PECAM-1/
CD31): frequent recognition by clinical isolates. Am J 
Trop Med Hyg 65: 47-51.
HO M, HICKEY MJ, MURRAY AG, ANDONEGUI G AND KUBES P.
2000. Visualization of Plasmodium falciparum-endothelium 
interactions in human microvasculature: mimicry of 
leukocyte recruitment. J Exp Med 192: 1205-1211.
HO M, HOANG HL, LEE KM, LIU N, MACRAE T, MONTES L,
FLATT CL, YIPP BG, BERGER BJ, LOOAREESUWAN S 
AND ROBBINS SM. 2005. Ectophosphorylation of CD36 
regulates cytoadherence of Plasmodium falciparum to 
microvascular endothelium under flow conditions. Infect 
Immun 73: 8179-8187.
HO M, SCHOLLAARDT T, NIU X, LOOAREESUWAN S, PATEL KD
AND KUBES P. 1998. Characterization of Plasmodium 
falciparum-infected erythrocyte and P-selectin interaction 
under flow conditions. Blood 91: 4803-4809.
HO M AND WHITE NJ. 1999. Molecular mechanisms of cytoad-
herence in malaria. Am J Physiol 276: C1231-1242.
HOLLESTELLE MJ, DONKOR C, MANTEY EA, CHAKRAVORTY
SJ, CRAIG A, AKOTO AO, O'DONNELL J, VAN MOURIK JA 
AND BUNN J. 2006. Von Willebrand factor propeptide in 
malaria: evidence of acute endothelial cell activation. Br J 
Haematol 133: 562-569.
HORA R, BRIDGES DJ, CRAIG A AND SHARMA A. 2009. Erythro-
cytic casein kinase II regulates cytoadherence of 
Plasmodium falciparum-infected red blood cells. J Biol 
Chem 284: 6260-6269.
HOTTA CT, GAZARINI ML, BERALDO FH, VAROTTI FP, LOPES
C, MARKUS RP, POZZAN T AND GARCIA CR. 2000. Calcium-
dependent modulation by melatonin of the circadian rhythm 
in malarial parasites. Nat Cell Biol 2: 466-468.
HOU DX AND KUMAMOTO T. 2010. Flavonoids as protein kinase
inhibitors for cancer chemoprevention: direct binding and 
molecular modeling. Antioxid Redox Signal 13: 691-719.
ISHINO T, ORITO Y, CHINZEI Y AND YUDA M. 2006. A calcium-
dependent protein kinase regulates Plasmodium ookinete 
access to the midgut epithelial cell. Mol Microbiol 59: 
1175-1184.
JURZYNSKI C, GYSIN J AND POUVELLE B. 2007. CD44, a signal
receptor for the inhibition of the cytoadhesion of CD36-
binding Plasmodium falciparum-infected erythrocytes 
by CSA- binding infected erythrocytes. Microbes Infect 
9: 1463-1470.
KATO N ET AL. 2008. Gene expression signatures and small-
molecule compounds link a protein kinase to Plasmodium 
falciparum motility. Nat Chem Biol 4: 347-356.
KEBAIER C AND VANDERBERG JP. 2010. Initiation of Plasmodium
sporozoite motility by albumin is associated with induction 
of intracellular signaling. Int J Parasitol 40: 25-33.
KOYAMA FC, CHAKRABARTI D AND GARCIA CR. 2009. Molecular
machinery of signal transduction and cell cycle regulation 
in Plasmodium. Mol Biochem Parasitol 165: 1-7.
KUMAR A, VAID A, SYIN C AND SHARMA P. 2004. PfPKB, a
novel protein kinase B-like enzyme from Plasmodium 
falciparum: I. Identification, characterization, and possible 
role in parasite development. J Biol Chem 279: 24255-24264.
KUREISHI Y, LUO Z, SHIOJIMA I, BIALIK A, FULTON D, LEFER D
J, SESSA WC AND WALSH K. 2000. The HMG-CoA 
reductase inhibitor simvastatin activates the protein kinase 
Akt and promotes angiogenesis in normocholesterolemic 
animals. Nat Med 6: 1004-1010.
LANGHORNE J, NDUNGU FM, SPONAAS AM AND MARSH K.
2008. Immunity to malaria: more question than answers. 
Nature Immunol 9: 725-732.
LANZER M, WICKERT H, KROHNE G, VINCENSINI L AND BRAUN
BRETON C. 2006. Maurer's clefts: a novel multi-functional 
organelle in the cytoplasm of Plasmodium falciparum-
infected erythrocytes. Int J Parasitol 36: 23-36.
LARKIN D ET AL. 2009. Severe Plasmodium falciparum malaria
is associated with circulating ultra-large von Willebrand 
multimers and ADAMTS13 inhibition. PLoS Pathog 5: 
e1000349.
LEDEBUR HC AND PARKS TP. 1995. Transcriptional regulation
of the intercellular adhesion molecule-1 gene by 
inflammatory cytokines in human endothelial cells. 
Essential roles of a variant NF-kappa B site and p65 
homodimers. J Biol Chem 270: 933-943.
LEECH JH, BARNWELL JW, MILLER LH AND HOWARD RJ. 1984.
Identification of a strain-specific malarial antigen exposed 
on the surface of Plasmodium falciparum-infected 
erythrocytes. J Exp Med 159: 1567-1575.
LEVANO-GARCIA JARD, DLUZEWSKI A, MARKUS RP AND
GARCIA CRS. 2011. Purinergic signaling is involved in the 
malaria parasite Plasmodium falciparum invasion to red 
blood cells. Purinergic Signaling 6: 365-372.
LI A, LIM TS, SHI H, YIN J, TAN SJ, LI Z, LOW BC, TAN KS AND
LIM CT. 2011. Molecular mechanistic insights into 
the endothelial receptor mediated cytoadherence of 
Plasmodium falciparum-infected erythrocytes. PLoS One 
6: e16929.
LIU J AND LIN A. 2005. Role of JNK activation in apoptosis:
a Double-edged sword. Cell Res 15: 36-42.
LOVETT JL AND SIBLEY LD. 2003. Intracellular calcium stores
in Toxoplasma gondii govern invasion of host cells. J Cell 
Sci 116: 3009-3016.
LOWENBERG EC ET AL. 2010. Severe malaria is associated with
a deficiency of von Willebrand factor cleaving protease, 
ADAMTS13. Thromb Haemost 103: 181-187.
An Acad Bras Cienc (2012) 84 (2)
569PLASMODIUM-RBC INTERACTIONS AND CYTOADHERENCE
MADEIRA L, DEMARCO R, GAZARINI ML, VERJOVSKI-ALMEIDA
S AND GARCIA CR. 2003. Human malaria parasites display 
a receptor for activated C kinase ortholog. Biochem 
Biophys Res Commun 306: 995-1001.
MAIER AG, COOKE BM, COWMAN AF AND TILLEY L. 2009.
Malaria parasite proteins that remodel the host erythrocyte. 
Nat Rev Microbiol 7: 341-354.
MASON JC. 2003. Statins and their role in vascular protection.
Clin Sci (Lond) 105: 251-266.
MAYOR A ET AL. 2011. Association of severe malaria outcomes
with platelet-mediated clumping and adhesion to a novel 
host receptor. PLoS One 6: e19422.
MCCALLUM-DEIGHTON N AND HOLDER AA. 1992. The role of
calcium in the invasion of human erythrocytes by Plasmodium 
falciparum. Mol Biochem Parasitol 50: 317-323.
MCCORMICK CJ, CRAIG A, ROBERTS D, NEWBOLD CI AND
BERENDT AR. 1997. Intercellular adhesion molecule-1 
and CD36 synergize to mediate adherence of Plasmodium 
falciparum-infected erythrocytes to cultured human 
microvascular endothelial cells. J Clin Invest 100: 2521-2529.
MCMORRAN BJ, MARSHALL VM, DE GRAAF C, DRYSDALE KE,
SHABBAR M, SMYTH GK, CORBIN JE, ALEXANDER WS 
AND FOOTE SJ. 2009. Platelets kill intraerythrocytic 
malarial parasites and mediate survival to infection. 
Science 323: 797-800.
MCROBERT L, TAYLOR CJ, DENG W, FIVELMAN QL, CUMMINGS
RM, POLLEY SD, BILLKER O AND BAKER DA. 2008. 
Gametogenesis in malaria parasites is mediated by the 
cGMP-dependent protein kinase. PLoS Biol 6: e139.
MIHO N, ISHIDA T, KUWABA N, ISHIDA M, SHIMOTE-ABE K,
TABUCHI K, OSHIMA T, YOSHIZUMI M AND CHAYAMA K. 
2005. Role of the JNK pathway in thrombin-induced ICAM-
1 expression in endothelial cells. Cardiovasc Res 68: 289-298.
MUHIA DK, SWALES CA, DENG W, KELLY JM AND BAKER DA.
2001. The gametocyte-activating factor xanthurenic acid 
stimulates an increase in membrane-associated guanylyl 
cyclase activity in the human malaria parasite Plasmodium 
falciparum. Mol Microbiol 42: 553-560.
MULLER S, KAMMERBAUER C, SIMONS U, SHIBAGAKI N, LI LJ,
CAUGHMAN SW AND DEGITZ K. 1995. Transcriptional 
regulation of intercellular adhesion molecule-1: PMA-
induction is mediated by NF kappa B. J Invest Dermatol 
104: 970-975.
MUN EC, MAYOL JM, RIEGLER M, O'BRIEN TC, FAROKHZAD
OC, SONG JC, POTHOULAKIS C, HRNJEZ BJ AND 
MATTHEWS JB. 1998. Levamisole inhibits intestinal 
Cl- secretion via basolateral K+ channel blockade. 
Gastroenterology 114: 1257-1267.
NDUNGU FM, SANNI L, URBAN B, STEPHENS R, NEWBOLD CI,
MARSH K AND LANGHORNE J. 2006. CD4 T cells from 
malaria-nonexposed individuals respond to the CD36-
Binding Domain of Plasmodium falciparum erythrocyte 
membrane protein-1 via an MHC class II-TCR-
independent pathway. J Immunol 176: 5504-5512.
NEWBOLD C, WARN P, BLACK G, BERENDT A, CRAIG A, SNOW
B, MSOBO M, PESHU N AND MARSH K. 1997. Receptor-
specific adhesion and clinical disease in Plasmodium 
falciparum. Am J Trop Med Hyg 57: 389-398.
NICHOLSON AC, FRIEDA S, PEARCE A AND SILVERSTEIN RL.
1995. Oxidized LDL binds to CD36 on human monocyte-
derived macrophages and transfected cell lines. Evidence 
implicating the lipid moiety of the lipoprotein as the 
binding site. Arterioscler Thromb Vasc Biol 15: 269-275.
OCKENHOUSE CF, TANDON NN, MAGOWAN C, JAMIESON GA
AND CHULAY JD. 1989. Identification of a platelet 
membrane glycoprotein as a falciparum malaria 
sequestration receptor. Science 243: 1469-1471.
OCKENHOUSE CF, TEGOSHI T, MAENO Y, BENJAMIN C, HO M,
KAN KE, THWAY Y, WIN K, AIKAWA M AND LOBB RR. 
1992. Human vascular endothelial cell adhesion receptors 
for Plasmodium falciparum-infected erythrocytes: roles 
for endothelial leukocyte adhesion molecule 1 and vascular 
cell adhesion molecule 1. J Exp Med 176: 1183-1189.
OKAMOTO H, YOSHIO T, KANEKO H AND YAMANAKA H. 2010.
Inhibition of NF-kappaB signaling by fasudil as a potential 
therapeutic strategy for rheumatoid arthritis. Arthritis 
Rheum 62: 82-92.
ONO T ET AL. 2008. Adenylyl cyclase alpha and cAMP signaling
mediate Plasmodium sporozoite apical regulated exocytosis 
and hepatocyte infection. PLoS Pathog 4: e1000008.
PAIN A, FERGUSON DJ, KAI O, URBAN BC, LOWE B, MARSH
K AND ROBERTS DJ. 2001. Platelet-mediated clumping 
of Plasmodium falciparum-infected erythrocytes is a 
common adhesive phenotype and is associated with 
severe malaria. Proc Natl Acad Sci USA 98: 1805-1810.
PAPI A AND JOHNSTON SL. 1999. Rhinovirus infection induces
expression of its own receptor intercellular adhesion 
molecule 1 (ICAM-1) via increased NF-kappaB-mediated 
transcription. J Biol Chem 274: 9707-9720.
PATTERSON RL, VAN ROSSUM DB, BARROW RK AND SNYDER
SH. 2004. RACK1 binds to inositol 1,4,5-trisphosphate 
receptors and mediates Ca2+ release. Proc Natl Acad Sci 
USA 101: 2328-2332.
PINTO A, SORRENTINO R AND SORRENTINO L. 1990. Levamisole
inhibits in vivo rat platelet aggregation by a release of 
prostacyclin-like factor. Gen Pharmacol 21: 255-259.
POBER JS. 2002. Endothelial activation: intracellular signaling
pathways. Arthritis Res 4(Suppl 3): S109-116.
PODREZ EA ET AL. 2002. Identification of a novel family of
oxidized phospholipids that serve as ligands for the macrophage 
scavenger receptor CD36. J Biol Chem 277: 38503-38516.
RAABE AC, WENGELNIK K, BILLKER O AND VIAL HJ. 2011.
Multipleroles for Plasmodium berghei phosphoinositide-
specific phospholipase C in regulating gametocyte 
activation and differentiation. Cell Microbiol 13: 955-966.
RAHMAN A, ANWAR KN, TRUE AL AND MALIK AB. 1999.
Thrombin-induced p65 homodimer binding to downstream 
NF-kappa B site of the promoter mediates endothelial 
ICAM-1 expression and neutrophil adhesion. J Immunol 
162: 5466-5476.
An Acad Bras Cienc (2012) 84 (2)
570 LAURA N. CRUZ,YANG WU, ALISTER G. CRAIG and CÉLIA R.S. GARCIA
RANGACHARI K, DLUZEWSKI A, WILSON RJ AND GRATZER WB.
1986. Control of malarial invasion by phosphorylation of 
the host cell membrane cytoskeleton. Nature 324: 364-365.
ROBERTS DD, SHERWOOD JA, SPITALNIK SL, PANTON LJ,
HOWARD RJ, DIXIT VM, FRAZIER WA, MILLER LH AND 
GINSBURG V. 1985. Thrombospondin binds falciparum 
malaria parasitized erythrocytes and may mediate 
cytoadherence. Nature 318: 64-66.
ROBLES MS, BOYAULT C, KNUTTI D, PADMANABHAN K AND
WEITZ CJ. 2010. Identification of RACK1 and protein 
kinase Calpha as integral components of the mammalian 
circadian clock. Science 327: 463-466.
ROIKO MS AND CARRUTHERS VB. 2009. New roles for perforins
and proteases in apicomplexan egress. Cell Microbiol 11: 
1444-1452.
ROMANO M, MEZZETTI A, MARULLI C, CIABATTONI G, FEBO F,
DI IENNO S, ROCCAFORTE S, VIGNERI S, NUBILE G, 
MILANI M AND DAVI G. 2000. Fluvastatin reduces soluble 
P-selectin and ICAM-1 levels in hypercholesterolemic 
patients: role of nitric oxide. J Investig Med 48: 183-189.
ROWE JA, CLAESSENS A, CORRIGAN RA AND ARMAN M. 2009.
Adhesion of Plasmodium falciparum-infected erythrocytes 
to human cells: molecular mechanisms and therapeutic 
implications. Expert Rev Mol Med 11: e16.
RUSSO I, BABBITT S, MURALIDHARAN V, BUTLER T, OKSMAN
A AND GOLDBERG DE. 2010. Plasmepsin V licenses 
Plasmodium proteins for export into the host erythrocyte. 
Nature 463: 632-636.
RUSSO I, OKSMAN A, VAUPEL B AND GOLDBERG DE. 2009. A
calpain unique to alveolates is essential in Plasmodium 
falciparum and its knockdown reveals an involvement 
in pre-S-phase development. Proc Natl Acad Sci USA 
106: 1554-1559.
SARTORELLO R, AMAYA MJ, NATHANSON MH AND GARCIA CR.
2009. The plasmodium receptor for activated C kinase 
protein inhibits Ca(2+) signaling in mammalian cells. 
Biochem Biophys Res Commun 389: 586-592.
SATTERLEE JS AND SUSSMAN MR. 1998. Unusual membrane-
associated protein kinases in higher plants. J Membr Biol 
164: 205-213.
SCHECHTMAN D AND MOCHLY-ROSEN D. 2001. Adaptor proteins
in protein kinase C-mediated signal transduction. 
Oncogene 20: 6339-6347.
SCHOFIELD L, NOVAKOVIC S, GEROLD P, SCHWARZ RT,
MCCONVILLE MJ AND TACHADO SD. 1996. 
Glycosylphosphatidylinositol toxin of Plasmodium up-
regulates intercellular adhesion molecule-1, vascular 
cell adhesion molecule-1, and E-selectin expression in 
vascular endothelial cells and increases leukocyte and 
parasite cytoadherence via tyrosine kinase-dependent 
signal transduction. J Immunol 156: 1886-1896.
SICARD A ET AL. 2011. Activation of a PAK-MEK signaling
pathway in malaria parasite-infected erythrocytes. Cell 
Microbiol 13: 836-845.
SILVERSTEIN RL, BAIRD M, LO SK AND YESNER LM. 1992.
Sense and antisense cDNA transfection of CD36 
(glycoprotein IV) in melanoma cells. Role of CD36 as a 
thrombospondin receptor. J Biol Chem 267: 16607-16612.
SINGH S, ALAM MM, PAL-BHOWMICK I, BRZOSTOWSKI JA AND
CHITNIS CE. 2010. Distinct external signals trigger 
sequential release of apical organelles during erythrocyte 
invasion by malaria parasites. PLoS Pathog 6: e1000746.
SNOW RW, GUERRA CA, NOOR AM, MYINT HY AND HAY SI.
2005. The global distribution of clinical episodes of 
Plasmodium falciparum malaria. Nature 434: 214-217.
SRIVASTAVA K ET AL. 2008. Platelet factor 4 mediates inflammation
in experimental cerebral malaria. Cell Host Microbe 
4: 179-187.
TACHADO SD, GEROLD P, MCCONVILLE MJ, BALDWIN T, QUILICI
D, SCHWARZ RT AND SCHOFIELD L. 1996. Glycosylphos-
phatidylinositol toxin of Plasmodium induces nitric 
oxide synthase expression in macrophages and vascular 
endothelial cells by a protein tyrosine kinase-dependent 
and protein kinase C-dependent signaling pathway. J 
Immunol 156: 1897-1907.
TACHADO SD, GEROLD P, SCHWARZ R, NOVAKOVIC S,
MCCONVILLE M AND SCHOFIELD L. 1997. Signal 
transduction in macrophages by glycosylphosphatidylino-
sitols of Plasmodium, Trypanosoma, and Leishmania: 
activation of protein tyrosine kinases and protein kinase C 
by inositolglycan and diacylglycerol moieties. Proc Natl 
Acad Sci USA 94: 4022-4027.
TANDON NN, KRALISZ U AND JAMIESON GA. 1989. Identification
of glycoprotein IV (CD36) as a primary receptor for 
platelet-collagen adhesion. J Biol Chem 264: 7576-7583.
TAOUFIQ Z, GAY F, BALVANYOS J, CICERON L, TEFIT M, LECHAT
P AND MAZIER D. 2008. Rho kinase inhibition in severe 
malaria: thwarting parasite-induced collateral damage to 
endothelia. J Infect Dis 197: 1062-1073.
TAOUFIQ Z, PINO P, N'DILIMABAKA N, ARROUSS I, ASSI S,
SOUBRIER F, REBOLLO A AND MAZIER D. 2011. Atorvas-
tatin prevents Plasmodium falciparum cytoadherence and 
endothelial damage. Malar J 10: 52.
TAYLOR HM, MCROBERT L, GRAINGER M, SICARD A, DLUZEWSKI
AR, HOPP CS, HOLDER AA AND BAKER DA. 2010. The 
malaria parasite cyclic GMP-dependent protein kinase plays a 
central role in blood-stage schizogony. Eukaryot Cell 9: 37-45.
TREUTIGER CJ, HEDDINI A, FERNANDEZ V, MULLER WA AND
WAHLGREN M. 1997. PECAM-1/CD31, an endothelial 
receptor for binding Plasmodium falciparum-infected 
erythrocytes. Nat Med 3: 1405-1408.
TRIPATHI AK, SHA W, SHULAEV V, STINS MF AND SULLIVAN JR
DJ. 2009. Plasmodium falciparum-infected erythrocytes 
induce NF-kappaB regulated inflammatory pathways in 
human cerebral endothelium. Blood 114: 4243-4252.
TRIPATHI AK, SULLIVAN DJ AND STINS MF. 2006. Plasmodium
falciparum-infected erythrocytes increase intercellular 
adhesion molecule 1 expression on brain endothelium 
through NF-kappaB. Infect Immun 74: 3262-3270.
An Acad Bras Cienc (2012) 84 (2)
571PLASMODIUM-RBC INTERACTIONS AND CYTOADHERENCE
TURNER GD ET AL. 1994. An immunohistochemical study of
the pathology of fatal malaria. Evidence for widespread 
endothelial activation and a potential role for intercellular 
adhesion molecule-1 in cerebral sequestration. Am J 
Pathol 145: 1057-1069.
UDOMSANGPETCH R, REINHARDT PH, SCHOLLAARDT T, ELLIOTT
JF, KUBES P AND HO M. 1997. Promiscuity of clinical 
Plasmodium falciparum isolates for multiple adhesion 
molecules under flow conditions. J Immunol 158: 4358-4364.
URBAN BC, FERGUSON DJ, PAIN A, WILLCOX N, PLEBANSKI M,
AUSTYN JM AND ROBERTS DJ. 1999. Plasmodium 
falciparum-infected erythrocytes modulate the maturation 
of dendritic cells. Nature 400: 73-77.
VAID A, RANJAN R, SMYTHE WA, HOPPE HC AND SHARM P.
2010. PfPI3K, a phosphatidylinositol-3 kinase from 
Plasmodium falciparum, is exported to the host 
erythrocyte and is involved in hemoglobin trafficking. 
Blood 115: 2500-2507.
VAID A AND SHARMA P. 2006. PfPKB, a protein kinase B-like
enzyme from Plasmodium falciparum: II. Identification of 
calcium/calmodulin as its upstream activator and dissection 
of a novel signaling pathway. J Biol Chem 281: 27126-27133.
VAID A, THOMAS DC AND SHARMA P. 2008. Role of Ca2+/
calmodulin-PfPKB signaling pathway in erythrocyte inva sion 
by Plasmodium falciparum. J Biol Chem 283: 5589-5597.
VANHAESEBROECK B AND ALESSI DR. 2000. The PI3K-PDK1
connection: more than just a road to PKB. Biochem J 346 
(Pt 3): 561-576.
VIEBIG NK, WULBRAND U, FORSTER R, ANDREWS KT, LANZER
M AND KNOLLE PA. 2005. Direct activation of human 
endothelial cells by Plasmodium falciparum-infected 
erythrocytes. Infect Immun 73: 3271-3277.
VOGETSEDER W AND DIERICH MP. 1991. Intercellular adhesion
molecule-1 (ICAM-1, CD 54) is associated with actin-
filaments. Immunobiology 182: 143-151.
WAKNINE-GRINBERG JH, MCQUILLAN JA, HUNT N, GINSBURG
H AND GOLENSER J. 2010. Modulation of cerebral malaria 
by fasudil and other immune-modifying compounds. Exp 
Parasitol 125: 141-146.
WANG Q, PFEIFFER GR 2ND, STEVENS T AND DOERSCHUK CM.
2002. Lung microvascular and arterial endothelial cells 
differ in their responses to intercellular adhesion molecule-1 
ligation. Am J Respir Crit Care Med 166: 872-877.
WARD P, EQUINET L, PACKER J AND DOERIG C. 2004. Protein
kinases of the human malaria parasite Plasmodium falciparum: 
the kinome of a divergent eukaryote. BMC Genomics 5: 79.
WASSMER SC, COMBES V, CANDAL FJ, JUHAN-VAGUE I AND
GRAU GE. 2006a. Platelets potentiate brain endothelial 
alterations induced by Plasmodium falciparum. Infect 
Immun 74: 645-653.
WASSMER SC, DE SOUZA JB, FRERE C, CANDAL FJ, JUHAN-
VAGUE I AND GRAU GE. 2006b. TGF-beta1 released from 
activated platelets can induce TNF-stimulated human brain 
endothelium apoptosis: a new mechanism for microvascular 
lesion during cerebral malaria. J Immunol 176: 1180-1184.
WASSMER SC, LEPOLARD C, TRAORE B, POUVELLE B, GYSIN J
AND GRAU GE. 2004. Platelets reorient Plasmodium 
falciparum-infected erythrocyte cytoadhesion to activated 
endothelial cells. J Infect Dis 189: 180-189.
WASSMER SC, TAYLOR T, MACLENNAN CA, KANJALA M,
MUKAKA M, MOLYNEUX ME AND GRAU GE. 2008. 
Platelet-induced clumping of Plasmodium falciparum-
infected erythrocytes from Malawian patients with 
cerebral malaria-possible modulation in vivo by 
thrombocytopenia. J Infect Dis 197: 72-78.
WOLFRUM S, JENSEN KS AND LIAO JK. 2003. Endothelium-
dependent effects of statins. Arterioscler Thromb Vasc 
Biol 23: 729-736.
WU Y, WANG X, LIU X AND WANG Y. 2003. Data-mining
approaches reveal hidden families of proteases in the 
genome of malaria parasite. Genome Res 13: 601-616.
WURTZ N, CHAPUS C, DESPLANS J AND PARZY D. 2011. cAMP-
dependent protein kinase from Plasmodium falciparum: 
an update. Parasitology 138: 1-25.
WURTZ N, DESPLANS J AND PARZY D. 2009. Phenotypic and
transcriptomic analyses of Plasmodium falciparum 
protein kinase A catalytic subunit inhibition. Parasitol Res 
105: 1691-1699.
WYKES MN AND GOOD MF. 2008. What really happens to dendritic
cells during malaria? Nat Rev Microbiol 6: 864-870.
XUE J, THIPPEGOWDA PB, HU G, BACHMAIER K, CHRISTMAN
JW, MALIK AB AND TIRUPPATHI C. 2009. NF-kappaB 
regulates thrombin-induced ICAM-1 gene expression in 
cooperation with NFAT by binding to the intronic NF-kappaB 
site in the ICAM-1 gene. Physiol Genomics 38: 42-53.
YIPP BG, BARUCH DI, BRADY C, MURRAY AG, LOOAREESUWAN
S, KUBES P AND HO M. 2003a. Recombinant PfEMP1 peptide 
inhibits and reverses cytoadherence of clinical Plasmodium 
falciparum isolates in vivo. Blood 101: 331-337.
YIPP BG, ROBBINS SM, RESEK ME, BARUCH DI, LOOAREE-
SUWAN S AND HO M. 2003b. Src-family kinase signaling 
modulates the adhesion of Plasmodium falciparum on human 
microvascular endothelium under flow. Blood 101: 2850-2857.
YUAN J ET AL. Chemical genomic profiling for antimalarial
therapies, response signatures, and molecular targets. 
Science 333: 724-729.
ZANG-EDOU ES, BISVIGOU U, TAOUFIQ Z, LEKOULOU F, LEKANA-
DOUKI JB, TRAORE Y, MAZIER D AND TOURE-NDOUO FS. 
2010. Inhibition of Plasmodium falciparum field isolates-
mediated endothelial cell apoptosis by Fasudil: therapeutic 
implications for severe malaria. PLoS One 5: e13221.
ZHOU Q AND LIAO JK. 2009. Statins and cardiovascular diseases:
from cholesterol lowering to pleiotropy. Curr Pharm Des 
15: 467-478.
